Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Maya A, Guglin"'
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Patients with severe aortic stenosis (AS) and left ventricular (LV) dysfunction demonstrate improvement in left ventricular injection fraction (LVEF) after aortic valve replacement (AVR). The timing and magnitude of recovery in pa
Externí odkaz:
https://doaj.org/article/00d67a8adcc04a83a835f6934e1e6ad3
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 5, p 1849 (2023)
Background: Myocarditis, diagnosed by symptoms and troponin elevation, has been well-described with COVID-19 infection, as well as shortly after COVID-19 vaccination. The literature has characterized the outcomes of myocarditis following COVID-19 inf
Externí odkaz:
https://doaj.org/article/b9afe92d7c8443a9a233ef70e08dd8f4
Publikováno v:
Heart Rhythm. 20:918-926
Autor:
Jeffrey J. Chapa, Jonathan C. McCollum, Janina Quintero Bisono, Rishika S. Prakash, Maya E. Guglin, Roopa A. Rao
Publikováno v:
Current Heart Failure Reports.
Publikováno v:
Heart & Lung. 52:174-181
Publikováno v:
Journal of Cardiac Failure. 29:614-615
Heart failure continues to account for millions of cases and deaths worldwide. Heart transplant is the gold standard for treatment of advanced heart failure. Unfortunately, the supply of donor hearts continues to be limited with the increase in deman
Publikováno v:
Journal of the American College of Cardiology. 81:927
Autor:
Sean Johnson, Saad Ali, Chirag D. Shah, Huseyin Arman, Radoslaw Nabrzyski, Hussein Elsemesmani, David Wong, Ryan Gandy, Mounir Al-Gibbawi, Hesham Omar, Bhavana Siddegowda Bangalore, Michael Duncan, Maya E. Guglin
Publikováno v:
Journal of the American College of Cardiology. 81:1908
Publikováno v:
Journal of the American College of Cardiology. 81:2663
Autor:
Onyedika J. Ilonze, Maya E. Guglin
Publikováno v:
Heart failure reviews. 27(6)
Clinical course and outcomes of myocarditis after COVID-19 vaccination remain variable. We retrospectively collected data on patients gt; 12 years old from 01/01/2021 to 12/30/2021 who received COVID-19 messenger RNA (mRNA) vaccination and were diagn